PMV Pharma
PMVP----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: PMV Pharma(PMVP) the EBIT is -18.88 M (+17.47%), Beat estimate;the EPS is -0.34 (+17.07%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.02B17.47%
-0.02B9.45%
+0.00B8.02%
EPSExceed expectations
-0.3417.07%
-0.38755.49%
+0.047511.58%
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly